Company news
Alector, Inc. news in 2019
Alector, Inc.'s news releases, calls and decks from 2019, newest first.
Alector Added to the NASDAQ Biotechnology Index
December 19, 2019
Alector Showcases Progress in Immuno-Neurology Clinical Programs and Research Portfolio at R&D Day
December 12, 2019
Alector Appoints Dr. Richard Scheller, Lasker Prize Awarded Scientist, and Dr. Thomas Südhof, Nobel Laureate as Co-Chairs of its Strategic Portfolio Advice and Review Committee
December 12, 2019
Alector Announces Appointment of Shehnaaz Suliman, M.D., MBA, M.Phil., as President and Chief Operating Officer
December 10, 2019
Alector Announces Phase 1 Data on AL002 at the 12th Clinical Trials on Alzheimer’s Disease (CTAD) Meeting
December 5, 2019
Alector Announces FDA Fast Track Designation Granted to AL001 for the Treatment of Patients with Frontotemporal Dementia
December 4, 2019
Alector to Host R&D Day on December 13, 2019
December 3, 2019
Alector to Present at the Jefferies 2019 London Healthcare Conference
November 13, 2019
Alector Reports Recent Business Highlights and Third Quarter 2019 Financial Results
November 11, 2019
Alector Initiates Phase 2 Trial of AL001 in Patients with Frontotemporal Dementia
September 8, 2019